Skip to main content

Unable to load price data. Sorry.


Pharmaceutical Product Development, Inc. (NASDAQ:PPDI.DL)

CAPS Rating: No stars

The Company is a global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering programs.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:PPDI.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

A6EIntruder (< 20)
Submitted June 02, 2009

Once upon a time I worked for a CRO called Quintiles, which has since gone back to being a private company--and remains the biggest CRO in the field today. I was on their contract sales side, so I can't claim any clinical experience. However, even at… More

dexion10 (26.48)
Submitted October 25, 2007

The biz model of developing drugs internally will prove to be a drag on this company - the drugs they buy are drugs that other pharmas didn't want... for example their Statin drug and diabetes candidates are also rans.... nothing exceptional. Worse… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about PPDI.DL.

No one has written a Pitch for PPDI.DL stock yet. Tell us why you think PPDI.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in PPDI.DL.

No players have picked PPDI.DL yet. Tell us why you think PPDI.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PPDI.DL.